Specgx Llc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is METHYLPHENIDATE BASE, with a corresponding US DMF Number 13132.
Remarkably, this DMF maintains an Active status since its submission on August 12, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 17, 2013, and payment made on February 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II